Atypical Central Serous Chorioretinopathy

Article Properties
Cite
Cebeci, Zafer, et al. “Atypical Central Serous Chorioretinopathy”. Turkish Journal of Ophthalmology, vol. 47, no. 4, 2017, pp. 238-42, https://doi.org/10.4274/tjo.38039.
Cebeci, Z., Oray, M., Bayraktar, Şerife, Tuğal Tutkun, İlknur, & Kır, N. (2017). Atypical Central Serous Chorioretinopathy. Turkish Journal of Ophthalmology, 47(4), 238-242. https://doi.org/10.4274/tjo.38039
Cebeci Z, Oray M, Bayraktar Şerife, Tuğal Tutkun İlknur, Kır N. Atypical Central Serous Chorioretinopathy. Turkish Journal of Ophthalmology. 2017;47(4):238-42.
Journal Category
Medicine
Ophthalmology
Citations Analysis
The category Medicine: Ophthalmology 6 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Methylprednisolone and was published in 2017. The most recent citation comes from a 2023 study titled Surgical Treatment of Bullous Exudative Retinal Detachment Secondary to Atypical Bilateral Central Serous Chorioretinopathy. This article reached its peak citation in 2022, with 4 citations. It has been cited in 9 different journals, 22% of which are open access. Among related journals, the Turkish Journal of Ophthalmology cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year